Boosting physical activity with tech, social support, and stress resilience
Increasing Physical Activity Through Social Support and Stress Resilience (I-PASS) Among Older Adults Living Alone With SCD to Lower ADRD Risk
This study tests whether adding technology-based tools plus social support and stress-resilience activities helps older adults living alone with subjective cognitive decline become more physically active.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 86 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Arizona State University Academic / other |
| Locations | 1 site (Phoenix, Arizona) |
| Trial ID | NCT06896825 on ClinicalTrials.gov |
What this trial studies
Older adults who live alone, report mild cognitive decline, and are currently sedentary will be enrolled and assigned to a tech-enhanced program or a basic program that both include education, goal-setting, and self-monitoring of activity. Participants will use a wearable activity monitor and receive weekly text reminders while researchers measure changes in moderate-to-vigorous physical activity over time. The study also measures social support and stress-resilience to see whether those psychosocial factors change and whether they explain any activity gains. Data collection combines objective activity tracking with questionnaires at baseline and follow-up visits conducted at the study site.
Who should consider this trial
Good fit: Ideal candidates are community-dwelling adults aged 60 or older who live alone, report a decline in cognitive function, do 60 minutes or less of moderate-to-vigorous activity per week, and own or are willing to use a smartphone in English.
Not a fit: People who are already regularly active, who have medical contraindications to increased activity (unless cleared by their physician), who cannot use a smartphone, or who cannot attend site visits are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the approach could help participants increase their physical activity while strengthening social support and stress resilience.
How similar studies have performed: Previous trials using wearables, reminders, and social support have increased activity in older adults, although combining technology enhancements with formal stress-resilience training is less well studied.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 60 years or older * Living alone and community dwelling * Engaging in 60 minutes or less per week of self-reported moderate-to-vigorous physical activity at screening (based on Exercise Vital Sign Questionnaire) * Self-reported decline in cognitive functioning * Self-reported ownership of/willingness to use a smartphone with an iOS or Android operating system (necessary for participants to track their activity using a wearable activity monitor). * Able to read and speak in English. We hope to offer the intervention in Spanish in the future; however, currently, the study materials are only available in English, and participation will require ability to read and respond to study materials. Exclusion Criteria: * Endorsing an item on the Physical Activity Readiness Questionnaire (PAR-Q), unless a physician's note is provided * Resting blood pressure greater than 200/110 mmHG as assessed at the baseline study assessment (unless a physician's note is provided) * Plans to relocate out of metropolitan Phoenix, Arizona area in the next 6 months * Participation in another physical activity, nutrition or weight loss program at time of screening or at any time during the intervention * Individuals with mild cognitive impairment (MCI), as determined by either a self-report of receiving a diagnosis of MCI from a health care provider or as assessed by the Telephone-Montreal Cognitive Assessment (T-MoCA) at the Baseline Session. A score \< 18 is an exclusion criterion. * Individuals with neurodegenerative (e.g., dementia), developmental (e.g., autism), neurologic (e.g., Parkinson's, epilepsy), or major psychiatric (e.g., bipolar, schizophrenia) diagnoses * Being previously prescribed one of the 5 approved Alzheimer's medications, including: Donepezil (Aricept), Rivastigmine (Exelon), Galantamine (Razadyne), Memantine (Namenda), Memantine + Donepezil (Namzaric) * Score of 9 or higher on the 15-item Geriatric Depression Scale (GDS) at the Baseline Session \[scores of 9 and higher are indicative of moderate to severe depression\] * History of stroke * Incarcerated individuals (i.e., Prisoners)
Where this trial is running
Phoenix, Arizona
- Arizona State University — Phoenix, Arizona, United States (Recruiting)
Study contacts
- Principal investigator: Molly Maxfield — Arizona State University
- Study coordinator: Molly Maxfield, PhD
- Email: Molly.Maxfield@asu.edu
- Phone: 602-496-2311
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.